MedPath
HSA Approval

UPLORES CAPSULE 150 mg

SIN11413P

UPLORES CAPSULE 150 mg

UPLORES CAPSULE 150 mg

October 20, 2000

EURO ASIA MEDICO PTE. LTD.

EURO ASIA MEDICO PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantEURO ASIA MEDICO PTE. LTD.
Licence HolderEURO ASIA MEDICO PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

J01FA06

roxithromycin

Manufacturer Information

EURO ASIA MEDICO PTE. LTD.

PT SANBE FARMA

Active Ingredients

ROXITHROMYCIN

150 mg

Roxithromycin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.